Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 9 studies | 29% ± 7% | |
| endothelial cell | 8 studies | 21% ± 5% | |
| enterocyte | 6 studies | 33% ± 5% | |
| epithelial cell | 6 studies | 33% ± 11% | |
| ionocyte | 3 studies | 33% ± 3% | |
| goblet cell | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 4 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6726.74 | 1445 / 1445 | 100% | 49.81 | 183 / 183 |
| pancreas | 100% | 2622.66 | 328 / 328 | 100% | 39.04 | 178 / 178 |
| prostate | 100% | 7208.47 | 245 / 245 | 100% | 46.26 | 502 / 502 |
| uterus | 100% | 6461.31 | 170 / 170 | 100% | 40.06 | 459 / 459 |
| stomach | 100% | 4491.48 | 359 / 359 | 100% | 50.80 | 285 / 286 |
| ovary | 100% | 5007.23 | 180 / 180 | 100% | 23.05 | 428 / 430 |
| thymus | 100% | 5852.86 | 653 / 653 | 100% | 41.67 | 602 / 605 |
| intestine | 100% | 9797.54 | 966 / 966 | 99% | 49.34 | 524 / 527 |
| brain | 100% | 5722.58 | 2634 / 2642 | 100% | 45.43 | 703 / 705 |
| breast | 100% | 5542.34 | 459 / 459 | 99% | 34.83 | 1109 / 1118 |
| skin | 100% | 5411.42 | 1809 / 1809 | 99% | 38.37 | 468 / 472 |
| adrenal gland | 100% | 4972.83 | 258 / 258 | 99% | 41.20 | 228 / 230 |
| kidney | 100% | 5769.46 | 89 / 89 | 99% | 32.97 | 891 / 901 |
| bladder | 100% | 6230.05 | 21 / 21 | 99% | 35.90 | 497 / 504 |
| liver | 100% | 2311.69 | 226 / 226 | 99% | 18.86 | 400 / 406 |
| lung | 100% | 5801.56 | 577 / 578 | 99% | 30.61 | 1138 / 1155 |
| adipose | 100% | 5203.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 38.64 | 80 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 38.39 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 19.85 | 1 / 1 |
| heart | 100% | 5038.17 | 860 / 861 | 0% | 0 | 0 / 0 |
| muscle | 100% | 4753.03 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5819.59 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3562.27 | 240 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 3.22 | 12 / 29 |
| peripheral blood | 7% | 75.90 | 61 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009649 | Biological process | entrainment of circadian clock |
| GO_1904888 | Biological process | cranial skeletal system development |
| GO_0071467 | Biological process | cellular response to pH |
| GO_0007188 | Biological process | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO_0007213 | Biological process | G protein-coupled acetylcholine receptor signaling pathway |
| GO_0007507 | Biological process | heart development |
| GO_0007207 | Biological process | phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway |
| GO_0007165 | Biological process | signal transduction |
| GO_0008217 | Biological process | regulation of blood pressure |
| GO_1990806 | Biological process | ligand-gated ion channel signaling pathway |
| GO_0060158 | Biological process | phospholipase C-activating dopamine receptor signaling pathway |
| GO_0032024 | Biological process | positive regulation of insulin secretion |
| GO_0048066 | Biological process | developmental pigmentation |
| GO_0045634 | Biological process | regulation of melanocyte differentiation |
| GO_0007603 | Biological process | phototransduction, visible light |
| GO_0001501 | Biological process | skeletal system development |
| GO_0086100 | Biological process | endothelin receptor signaling pathway |
| GO_0001508 | Biological process | action potential |
| GO_0099105 | Biological process | ion channel modulating, G protein-coupled receptor signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0001750 | Cellular component | photoreceptor outer segment |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0045202 | Cellular component | synapse |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005834 | Cellular component | heterotrimeric G-protein complex |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0031683 | Molecular function | G-protein beta/gamma-subunit complex binding |
| GO_0003925 | Molecular function | G protein activity |
| GO_0001664 | Molecular function | G protein-coupled receptor binding |
| GO_0005525 | Molecular function | GTP binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0030234 | Molecular function | enzyme regulator activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | GNA11 |
| Protein name | Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11) (Guanine nucleotide-binding protein G(y) subunit alpha) Guanine nucleotide-binding protein subunit alpha-11 |
| Synonyms | GA11 |
| Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems . Acts as an activator of phospholipase C . Transduces FFAR4 signaling in response to long-chain fatty acids (LCFAs) . Together with GNAQ, required for heart development (By similarity). . |
| Accessions | P29992 ENST00000078429.9 A0A087WVZ3 K7EL62 ENST00000588401.1 ENST00000587636.1 |
